Live, virtual training through WebEx

Co-Hosted by: Maryland Addiction Consultation Service (MACS) and MD Department of Human Services, Social Services Administration 

Audience: Primary Care Physicians, Advance Practice Registered Nurses, Physician Assistants, other members of the healthcare team

Learning Objectives:
Presenters:

Katie Mark, MD, FACOG 
Consultant, Maryland Addiction Consultation Service (MACS) for Maternal Opioid Misuse (MOMs) 

Shawnett Mills, LCPC
Social Services Administration, MD Department of Human Services 

Disclosure Information: 
Katie Mark, MD, FACOG, faculty for this activity has reported no relevant financial relationships to disclose. 
Shawnett Mills, LCPC, faculty for this activity has reported no relevant financial relationships to disclose. 
The planners and reviewers for this activity have reported no relevant financial relationships to disclose. 

Event contact: Bridget Sweeney, MACS Training Coordinator MACSTraining@som.umaryland.edu

CME Credit:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of MedChi, The Maryland State Medical Society and the Maryland Addiction Consultation Service (MACS). MedChi is accredited by the ACCME to provide continuing medical education for physicians. 

MedChi designates this virtual live webinar for a maximum of 1 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

CEU Credit:
Maryland Addiction Consultation Service (MACS) of the University of Maryland School of Medicine, Department of Psychiatry is authorized as a sponsor of Continuing Education Units. MACS maintains responsibility for this program.

MAT and MATE Acts: 

On December 29, 2022, President Biden signed the fiscal year 2023 omnibus, passing the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts. These bills were passed to expand access to buprenorphine for the treatment of opioid use disorder, and normalize and enhance substance use care across healthcare settings.

MACS is monitoring guidance from state and federal agencies closely and will update this page when more information becomes available. The resources on this page offer information about the omnibus, the bills, and the implications for healthcare providers and programs. Find out more here: https://www.marylandmacs.org/MAT--MATE-Acts/